Cargando…

Novel G9a/DNMT first-in-class dual reversible inhibitor has potent antitumor effect in bladder cancer

Detalles Bibliográficos
Autores principales:	Kwon, Whi-An, Seo, Ho Kyung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2020
Materias:	Editorial Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798466/ https://www.ncbi.nlm.nih.gov/pubmed/35117479 http://dx.doi.org/10.21037/tcr.2020.01.16

Ejemplares similares

Optimizing frontline therapy in advanced urothelial cancer
por: Kwon, Whi-An, et al.
Publicado: (2020)

The STAT3-DNMT1 connection
por: Thomas, N. Shaun B.
Publicado: (2012)

Reversible dual inhibitor against G9a and DNMT1 improves human iPSC derivation enhancing MET and facilitating transcription factor engagement to the genome
por: Rodriguez-Madoz, Juan Roberto, et al.
Publicado: (2017)

Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs in hematological malignancies
por: San José-Enériz, Edurne, et al.
Publicado: (2017)

Thioridazine has potent antitumor effects on lung cancer stem-like cells
por: Shen, Jiani, et al.
Publicado: (2017)

Electrostatic interaction of tumor-targeting adenoviruses with aminoclay acquires enhanced infectivity to tumor cells inside the bladder and has better cytotoxic activity
por: Kim, Soo-Yeon, et al.
Publicado: (2017)

A catalytic dependent role for DNMT3B in tumor suppression
por: Li, Haitao, et al.
Publicado: (2021)

Activity Landscape and Molecular Modeling to Explore the SAR of Dual Epigenetic Inhibitors: A Focus on G9a and DNMT1
por: López-López, Edgar, et al.
Publicado: (2018)

Dnmt3 and G9a Cooperate for Tissue-specific Development in Zebrafish
por: Rai, Kunal, et al.
Publicado: (2010)

A Single Domain–Based Anti-Her2 Antibody Has Potent Antitumor Activities
por: Wu, Xiaoqiong, et al.
Publicado: (2018)

Class effect for SGLT-2 inhibitors: a tale of 9 drugs
por: Giugliano, Dario, et al.
Publicado: (2019)

Animal Model of Interstitial Cystitis/Bladder Pain Syndrome
por: Kwon, Whi-An
Publicado: (2018)

CodeBreak 200: Sotorasib Has Not Broken the KRAS(G12C) Enigma Code
por: Zhang, Shannon S, et al.
Publicado: (2023)

Cytotoxic Mechanisms of FK317, a New Class of Bioreductive Agent with Potent Antitumor Activity
por: Naoe, Yoshinori, et al.
Publicado: (1998)

Antimicrobial peptides of the Cecropin-family show potent antitumor activity against bladder cancer cells
por: Suttmann, Henrik, et al.
Publicado: (2008)

Dnmt1 has de novo activity targeted to transposable elements
por: Haggerty, Chuck, et al.
Publicado: (2021)

Prostate Volume has Prognostic Value Only in Pathologic T2 Radical Prostatectomy Specimens
por: Cho, In-Chang, et al.
Publicado: (2011)

Gene editing using CRISPR/Cas9: implications for dual-use and biosecurity
por: DiEuliis, Diane, et al.
Publicado: (2017)

Trop-2-targeting tetrakis-ranpirnase has potent antitumor activity against triple-negative breast cancer
por: Liu, Donglin, et al.
Publicado: (2014)

A Novel Monoclonal Antibody Targeting Cancer-Specific Plectin Has Potent Antitumor Activity in Ovarian Cancer
por: Perez, Samantha M., et al.
Publicado: (2021)

Dnmt1 has an essential function despite the absence of CpG DNA methylation in the red flour beetle Tribolium castaneum
por: Schulz, Nora K. E., et al.
Publicado: (2018)

The establishment of a growth-controllable orthotopic bladder cancer model through the down-regulation of c-myc expression
por: Seo, Ho Kyung, et al.
Publicado: (2016)

CodeBreaK 200: Sotorasib (AMG510) Has Broken the KRAS G12C+ NSCLC Enigma Code
por: Brazel, Danielle, et al.
Publicado: (2023)

Oct4 and Hypoxia Dual-Regulated Oncolytic Adenovirus Armed with shRNA-Targeting Dendritic Cell Immunoreceptor Exerts Potent Antitumor Activity against Bladder Cancer
por: Hu, Che-Yuan, et al.
Publicado: (2023)

Antitumor activity of the c-Myc inhibitor KSI-3716 in gemcitabine-resistant bladder cancer
por: Seo, Ho Kyung, et al.
Publicado: (2014)

Approaches to Clinical Complete Response after Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer: Possibilities and Limitations
por: Lee, Hye Won, et al.
Publicado: (2023)

Learning From Heart Failure: How Will We Lead Bladder Failure Into the Future?
por: Kwon, Whi-An, et al.
Publicado: (2016)

Structural and biochemical insight into the mechanism of dual CpG site binding and methylation by the DNMT3A DNA methyltransferase
por: Emperle, Max, et al.
Publicado: (2021)

Usefulness of the mass screening program for colorectal cancer in China: further long-term validation is needed to confirm its value
por: Kwon, Whi-An, et al.
Publicado: (2020)

Emerging agents for the treatment of metastatic urothelial cancer
por: Kwon, Whi-An, et al.
Publicado: (2021)

Dual G9A/EZH2 Inhibition Stimulates Antitumor Immune Response in Ovarian High-Grade Serous Carcinoma
por: Spiliopoulou, Pavlina, et al.
Publicado: (2022)

Plocabulin, a novel tubulin inhibitor, has potent antitumor activity in patient-derived xenograft models of gastrointestinal stromal tumors
por: Wang, Yannick, et al.
Publicado: (2020)

The Role of Dual Red Imaging in Gastric Endoscopic Submucosal Dissection
por: Yoo, In Kyung, et al.
Publicado: (2020)

Has tamoxifen had its day?
por: Baum, Michael
Publicado: (2002)

Efficient targeted DNA methylation with chimeric dCas9–Dnmt3a–Dnmt3L methyltransferase
por: Stepper, Peter, et al.
Publicado: (2017)

CD4 T Cells and Their Role in Antitumor Immune Responses
por: Toes, René E.M., et al.
Publicado: (1999)

Antitumor activity of LSD1 inhibitors in lung cancer
por: Mohammad, Helai P., et al.
Publicado: (2016)

DNMT1 regulates expression of MHC class I in post-mitotic neurons
por: Gustafsson, Julie Ry, et al.
Publicado: (2018)

Synthesis, Characterization and Biological Evaluation of Some Quinoxaline Derivatives: A Promising and Potent New Class of Antitumor and Antimicrobial Agents
por: Al-Marhabi, Aisha R., et al.
Publicado: (2015)

Potent antitumor property of Allium bakhtiaricum extracts
por: Vafaee, Kosar, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_q48n3i4n4qjkk6lvamg7q5lj53